What is Strolll?
Founded in 2019 by Tom Finn, with Jorgen Ellis joining as Co-founder and CEO in 2020, Strolll is at the forefront of disrupting the neurorehabilitation market. The company has developed the world's first clinically validated digital therapeutic software platform. This innovative platform integrates digital content with real-world experiences by utilizing off-the-shelf AR glasses. Strolll's solution is specifically designed to assist individuals managing neurological conditions such as Parkinson's disease, stroke, and Multiple Sclerosis, offering a novel approach to patient care and recovery.
How much funding has Strolll raised?
Strolll has raised a total of $13.2M across 1 funding round:
Series A
$13.2M
Series A (2025): $13.2M with participation from IW Capital
Key Investors in Strolll
IW Capital
IW Capital is a venture capital firm that supports high-growth UK businesses by providing bespoke investment opportunities aimed at long-term growth and significant tax relief through the Enterprise Investment Scheme (EIS). The company focuses on backing ambitious founders and offers more than just capital, delivering essential connections and commitment to accelerate growth.
What's next for Strolll?
The recent major enterprise-level funding positions Strolll for significant scaling and further development of its groundbreaking digital therapeutic platform. This strategic investment is expected to accelerate market penetration, enhance clinical validation efforts, and potentially expand the company's reach to new patient populations and geographical regions. With a clear focus on innovation in neurorehabilitation, Strolll is poised to become a key player in the digital health sector, leveraging its technology to improve the lives of those affected by neurological disorders.
See full Strolll company page
